ReShape Lifesciences Inc. ETRM
Set alert
No live quote for ETRM yet.
- Open
- 1.98
- Prev close
- 1.98
- Mkt cap
- 29.86M
- Vol
- 1.06M
- Avg vol
- 918.94K
- EPS
- -6.50
- P/E
- -0.32
- Div yield
- 0.00%
More statistics
- Low
- 1.96
- High
- 2.09
- Forward P/E
- -3.20
- Beta
- 2.56
- Short ratio
- 5.33
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.94
- 200-d avg
- 3.58
- 1y target
- 6.50
Key statistics
- Market cap
- 29.86M
- Enterprise value
- 5.39M
- Trailing P/E
- -0.32
- Forward P/E
- -3.20
- PEG ratio
- -5.88
- Price / sales
- 52.22
- Price / book
- 0.45
- EPS (TTM)
- -6.50
- Beta
- 2.56
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 571.76K
- Revenue growth
- -66.30%
- Free cash flow
- -9.67M
- Total cash
- 11.20M
- Total debt
- 0
- Return on equity
- -146.32%
- Shares outstanding
- 14.57M
- Short % of float
- 16.31%
- 50-day average
- 1.94
- 200-day average
- 3.58
Analyst view
Consensus: strong buy
Next earnings
Consensus EPS estimate -0.29.
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 2, 2017 | Ladenburg Thalmann | init | — | Buy |
| Jun 8, 2016 | Roth Capital | down | — | Neutral |
| Oct 14, 2013 | Lake Street | init | — | Buy |
| Dec 19, 2012 | Roth Capital | init | — | Buy |
About ReShape Lifesciences Inc.
EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology, vBloc Therapy is designed to intermittently block the vagus nerve using electrical impulses. The company develops the vBloc System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Appliances & Equipment
- Country
- United States
- Website
- enteromedics.com
News
Your note
Sign in to keep a note on ETRM — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| GOLDFISCHER CARL | Director | Sale | May 24, 2017 | 0 |
| MASHAAL MICHAEL Y | Director | Ownership Statement | Oct 2, 2017 | 0 |
| NIHALANI RAJESH | Officer | Acquisition (Non Open Market) | May 21, 2017 | 978,845 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group, Inc. (The) | 0.49% | 49,740 | 251.68K | Jun 29, 2017 |
| Geode Capital Management, LLC | 0.26% | 26,825 | 135.73K | Jun 29, 2017 |
| Blackrock Inc. | 0.17% | 17,668 | 89.40K | Jun 29, 2017 |
| Dimensional Fund Advisors LP | 0.13% | 13,194 | 66.76K | Jun 29, 2017 |
| Bank of Montreal/Can/ | 0.09% | 9,600 | 17.09K | Sep 29, 2017 |
| UBS Group AG | 0.05% | 5,535 | 28.01K | Jun 29, 2017 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.39% | 39,971 | 225.84K | Mar 30, 2017 |
| iShares Micro Cap ETF | 0.16% | 16,277 | 82.36K | Jun 29, 2017 |
| Fidelity Extended Market Index Fund | 0.13% | 13,716 | 69.40K | Jun 29, 2017 |
| Fidelity Total Market Index Fund | 0.13% | 13,109 | 66.33K | Jun 29, 2017 |
| Claymore ETF Tr-Wilshire Micro Cap ETF | 0.02% | 2,375 | 12.02K | Jun 29, 2017 |